The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Differential pathologic complete response rates after neoadjuvant chemotherapy among molecular subtypes of triple-negative breast cancer.
Hiroko Masuda
No relevant relationships to disclose
Keith A. Baggerly
No relevant relationships to disclose
Ying Wang
No relevant relationships to disclose
Ya Zhang
No relevant relationships to disclose
Ana M. Gonzalez-Angulo
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose
Vicente Valero
No relevant relationships to disclose
Brian D. Lehmann
No relevant relationships to disclose
Jennifer A. Pietenpol
No relevant relationships to disclose
Gabriel N. Hortobagyi
No relevant relationships to disclose
William Fraser Symmans
No relevant relationships to disclose
Naoto T. Ueno
No relevant relationships to disclose